Brief rapamycin therapy in middle-aged mice extends lives
Researchers studying the biology of aging (geroscience) briefly treated middle-age mice with the drug rapamycin to gauge the long-term effects of short-term therapy on health and longevity. The results were published in the scientific journal eLife. August 26, 2016